Back
BeiGene Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Sell
41
BGNE
BeiGene
Last Price:
161.68
Seasonality Move:
20.4%
Buy
64
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
42.60
Seasonality Move:
-13.76%
Sell
41
BeiGene (BGNE)
is a Sell
Is BeiGene a Buy, Sell or Hold?
- The current BeiGene [BGNE] share price is $161.13. The Score for BGNE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- BGNE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Corbus Pharmaceuticals Holdings (CRBP)
is a Buy
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $42.99. The Score for CRBP is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- CRBP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BGNE Stock Price Chart
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $42.99
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRBP is experiencing slight buying pressure.
BGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.96 | Buy |
| Relative Strength Index (14 RSI): | 57.26 | Buy |
| Chaikin Money Flow: | -186703 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (137.55 - 160.99) | Buy |
| Bollinger Bands (100): | (146.18 - 172.38) | Buy |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.21 | Buy |
| Relative Strength Index (14 RSI): | 62.46 | Buy |
| Chaikin Money Flow: | 43649 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.04 - 41.28) | Buy |
| Bollinger Bands (100): | (13.36 - 40.92) | Buy |
BGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 162.26 | Sell |
| 20-day SMA: | 149.54 | Buy |
| 50-day SMA: | 155.06 | Buy |
| 200-day SMA: | 174.45 | Sell |
| 8-day EMA: | 161.11 | Buy |
| 20-day EMA: | 155.55 | Buy |
| 50-day EMA: | 155 | Buy |
| 200-day EMA: | 172.25 | Sell |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.23 | Buy |
| 20-day SMA: | 38.49 | Buy |
| 50-day SMA: | 38.92 | Buy |
| 200-day SMA: | 16.55 | Buy |
| 8-day EMA: | 40.74 | Buy |
| 20-day EMA: | 39.15 | Buy |
| 50-day EMA: | 36.07 | Buy |
| 200-day EMA: | 21.66 | Buy |
BeiGene Earnings Growth & BGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.77 per share, an increase next quarter of $1.11 per share, a decrease this year of $0.40 per share, and an increase next year of $4.99 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.48 per share, an increase this year of $5.00 per share, and an increase next year of $0.06 per share.
BeiGene Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||